RootPath Genomics

About:

RootPath Genomics is a biotechnology company developing a powerful personalized T cell therapy platform that bridges precision medicine.

Website: https://www.rootpath.com/

Top Investors: Matrix Partners China, HongShan, Sky9 Capital, CDH Investments, Oriza Seed Capital (Oriza Yuandian)

Description:

RootPath is a Cambridge-based biotechnology company developing a powerful personalized T cell therapy platform that bridges precision medicine and cancer immunotherapy. Their next generation technologies allow us to precisely monitor, modulate and steer the immune system for a revolution in the diagnosis and treatment of cancer.